Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCL.

Molecular therapy. Advances·2026
Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026
Same author

Bioinformatics and AI/ML approaches using multi-omics data to accelerate diagnosis and delivery of precision care for patients with rare diseases.

Methods in cell biology·2026
Same author

Telomere length as a marker of biological age in paediatric multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Out-of-Pocket and Total Health Care Costs Among Commercially Insured Adults and Children With Multiple Sclerosis.

JAMA neurology·2025
Same journal

Hepatitis B Infection-Associated Aortoarteritis.

Annals of Indian Academy of Neurology·2026
Same journal

Correspondence- Muscle Magnetic Resonance Imaging Phenotyping and Pattern Recognition in Genetically Confirmed Myopathies: A Large-Cohort Study from the Indian Subcontinent.

Annals of Indian Academy of Neurology·2026
Same journal

STAC3-Related Congenital Myopathy (CMYP13) in an Adult Indian Patient: Expanding the Geographic Spectrum to India.

Annals of Indian Academy of Neurology·2026
Same journal

A Prospective Study on Autonomic Functions in Idiopathic Inflammatory Myopathies: The AFIIM Study.

Annals of Indian Academy of Neurology·2026
Same journal

Magnetic Resonance Imaging Findings During Encephalopathic Crisis in Glutaric Aciduria Type 1: Expanding the Radiologic Phenotype.

Annals of Indian Academy of Neurology·2026
Same journal

Thyroid Function and Cognitive Health in Older Adults: Insights from the LASI-DAD Study.

Annals of Indian Academy of Neurology·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Pediatric multiple sclerosis.

Yashma Patel1, Vikram Bhise, Lauren Krupp

  • 1Department of Neurology. Stony Brook University Medical Center, Stony Brook, NY 11794 USA.

Annals of Indian Academy of Neurology
|February 26, 2010
PubMed
Summary
This summary is machine-generated.

Pediatric multiple sclerosis (MS) presents unique diagnostic challenges. Research in children offers insights into MS pathogenesis, with disease-modifying therapies showing promise for effective treatment.

Keywords:
Pediatric multiple sclerosis

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jun 15, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Neuroimmunology

Background:

  • Pediatric multiple sclerosis (MS) is a distinct subgroup with diagnostic complexities.
  • Children with MS may offer unique insights into MS pathogenesis due to environmental exposures and disease expression.
  • Acute disseminated encephalomyelitis (ADEM) is more common in children, complicating MS differential diagnosis.

Purpose of the Study:

  • To highlight the unique characteristics of pediatric MS.
  • To discuss diagnostic challenges, particularly differentiating from ADEM.
  • To address cognitive and psychosocial implications in young MS patients.

Main Methods:

  • Review of existing literature on pediatric MS and ADEM.
  • Comparison of clinical and MRI findings in pediatric MS versus adult MS.
  • Analysis of diagnostic criteria and therapeutic approaches.

Main Results:

  • Young children with MS show differences from adults, including lower frequency of oligoclonal bands and less distinct MRI lesions.
  • Encephalopathy is more characteristic of ADEM, aiding differential diagnosis.
  • Disease-modifying therapies are generally well-tolerated and appear effective in pediatric MS.

Conclusions:

  • Pediatric MS requires specialized diagnostic approaches and consideration of co-occurring conditions like ADEM.
  • Cognitive dysfunction and psychosocial adjustment are critical concerns requiring targeted interventions.
  • Multinational research collaborations are essential for advancing understanding and treatment of pediatric MS.